Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Cerner Corp. (CERN - Analyst Report) expanded its health information technology (HIT) solution client base to 24 countries by offering Cerner Millennium to a privately-owned 674-bed Hospital Israelita Albert Einstein in Brazil. The HIT solution will help improve the quality of patient care and streamline operations in the hospital.

The first phase of the project involves translation of Cerner Millennium into Portuguese, Orders, Documentation, electronic medical record (EMR), Pharmacy, Patient Management, Billing, ER, ICU, Oncology, Cardiology, Laboratory, Surgery, Ambulatory practice, Medication Administration, Women's Health and various Performance Improvement and Quality Outcomes solutions across the acute care facility and clinics in the hospital. Currently, the hospital has eight ambulatory clinics in Sao Paulo.

CERN started rising and has been hovering around its 52-week high recently following the announcement of a multiyear partnership with Utah-based non-profit health care provider Intermountain Healthcare, which has 22 hospitals, 185 clinics, a medical group comprising 1,000 physicians and a health plans division.

The partnership agreement will implement Cerner’s electronic medical record and revenue cycle solutions across all of Intermountain's hospitals and clinics. It will also develop a new set of tools for a post-fee-for-service world in areas such as activity-based costing. It is expected to generate more than $50 million in annual revenue for CERN.

Cerner reported a 14.3% rise in second-quarter 2013 earnings per share to 32 cents, meeting the Zacks Consensus Estimate. Net income rose 15.4% year over year to $112.9 million.

Revenues in the quarter rose 11.0% year over year to $707.6 million. However, it missed the Zacks Consensus Estimate of $724 million. The revenues growth was at the lower end of Cerner’s earlier assumptions due to reduced volume of tech resale, which carries a lower margin.

For the third quarter of 2013, CERN forecasts revenues in a band of $740 million–$770 million. Earnings per share, before share based compensation expense, are expected in the range of 35 cents to 36 cents. Cerner projects stock-based compensation costs to dilute second quarter earnings by about 2 cents to 3 cents.

For 2013, the company continues to forecast revenues in the region of $2,950 million to $3,050 million. Earnings per share, before share based compensation expense, are forecasted in the range of $1.40 and $1.42 (earlier $1.39 and $1.42). Cerner projects stock-based compensation costs to dilute earnings by about 8 cents to 9 cents.

Cerner carries a Zacks Rank #3 (Hold). While there are no other medical information systems stocks that are currently worth a look, we consider medical product stocks such as Bio-Rad Laboratories, Inc. (BIO - Snapshot Report) with a Zacks Rank #1 (Strong Buy), and Boston Scientific Corp. (BSX - Analyst Report) and Hospira Inc. (HSP - Analyst Report), both with a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%